Cargando…
COVID-19 neutralizing antibody-based therapies in humoral immune deficiencies: A narrative review
The outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS−COV-2), generated an unprecedented global health and social emergency. Despite many efforts from clinicians to develop effective anti−COVID-19 treatment protocols, no specific therapy...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839625/ https://www.ncbi.nlm.nih.gov/pubmed/33518427 http://dx.doi.org/10.1016/j.transci.2021.103071 |